FDA Panel Recommends Lip Indication for Medicis' RESTYLANE(R)
27 avr. 2011 16h52 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., April 27, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel (the...
Medicis Announces Availability of Online Proxy Materials for 2011
06 avr. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., April 6, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that proxy materials are available via the Internet for its 2011 Annual Meeting of Stockholders under the U.S....
Medicis Increases Quarterly Cash Dividend to $0.08 Per Share
22 mars 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 22, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.08 per issued and outstanding share of...
Medicis Named to "World's Most Ethical Companies" List
16 mars 2011 13h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 16, 2011 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (NYSE:MRX) is the only pharmaceutical company in the world named to the Ethisphere Institute's prestigious 2011...
Medicis to Present at Barclays Capital Healthcare Conference
14 mars 2011 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 14, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Barclays Capital 2011 Global Healthcare Conference in Miami,...
Medicis to Present at Cowen Healthcare Conference
04 mars 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 4, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 31st Annual Cowen Healthcare Conference in Boston,...
Medicis Reports Fourth Quarter and Year-End 2010 Results
25 févr. 2011 16h05 HE
|
Medicis Pharmaceutical Corporation
LipoSonix™ and Business Development Updates
SCOTTSDALE, Ariz., Feb. 25, 2011 (GLOBE NEWSWIRE) --
2010 Financial Highlights
Revenues increased approximately 22.4%
Non-GAAP net...
Medicis Announces 2010 Fourth Quarter and Year-End Conference Call and Webcast
23 févr. 2011 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2010 fourth quarter and year-end financial results after the market closes on...
Medicis and Anacor Enter Into Research and Development Collaboration for the Treatment of Acne
10 févr. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz. and PALO ALTO, Calif., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (NYSE:MRX) and Anacor Pharmaceuticals, Inc. (Nasdaq:ANAC) today announced that the two...
Medicis to Present at J.P. Morgan Healthcare Conference
06 janv. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Jan. 6, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco,...